# Milestone Pharmaceuticals Inc.: Form D filings

Milestone Pharmaceuticals Inc., a pharmaceuticals company in Montreal, Quebec, Canada, filed 4 Form D notices with the SEC between 2011 and 2018. The latest, on October 26, 2018, reports $80 million sold of a $80 million offering to 16 investors.

Find out what Milestone Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Milestone%20Pharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Milestone%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmilestone-pharmaceuticals-inc-1408443)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Milestone%20Pharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Milestone%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmilestone-pharmaceuticals-inc-1408443)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1111 DR. FREDERIK-PHILIPS BLVD, SUITE 420, Montreal, Quebec, Canada, H4M 2
- Phone: (514) 336-0444
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Quebec, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1408443

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 26, 2018 | New notice | $80,000,000 | $80,000,000 | $0 | 16 | Oct 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1408443/000140844318000001/0001408443-18-000001-index.htm) |
| Jul 25, 2017 | New notice | $6,880,072 | $6,880,072 | $0 | 5 | Jul 21, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1408443/000140844317000002/0001408443-17-000002-index.htm) |
| Jun 15, 2015 | New notice | $9,406,593 | $3,848,369 | $5,558,224 | 3 | Jun 3, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1408443/000114420415037254/0001144204-15-037254-index.htm) |
| Jun 14, 2011 | New notice | $595,502 | $595,502 | $0 | 2 | May 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1408443/000140844311000004/0001408443-11-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Guy G. Rousseau | Executive Officer |  |
| Nilesh G. Kumar | Director |  |
| Debra G. Liebert | Director |  |
| Paul G. Truex | Director |  |
| Francis G. Plat | Executive Officer |  |
| Joseph G. Oliveto | Executive Officer, Director |  |
| Douglas G. Wight | Executive Officer |  |
| Philippe G. Douville | Executive Officer |  |
| Marco G. Boorsma | Director |  |
| Harish G. Pimplaskar | Executive Officer |  |
| Lorenz G. Muller | Executive Officer |  |
| Jeff G. Nelson | Executive Officer |  |

[Every Form D from the week of Oct 22, 2018](https://specstream.ai/data/form-d/week/2018-10-22) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Milestone Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).